Author Question: A public health nurse is involved in health care reform. Which of the following best explains why ... (Read 60 times)

Mimi

  • Hero Member
  • *****
  • Posts: 542
A public health nurse is involved in health care reform. Which of the following best explains why the nurse is involved in these efforts?
 
  a. To promote the nursing profession
  b. To increase funding for public health nursing
  c. To address the concerns of nurses
  d. To help improve health care access

Question 2

Why did the Metropolitan Life Insurance Company establish and retain for several years the first community nursing health program for policyholders?
 
  a. Creating such a service was the morally correct thing to do.
  b. Employing nurses directly was less expensive than paying taxes to the city for the same purpose.
  c. Having the company's nurses make home visits increased worker morale.
  d. Having public health nurses visit policyholders and their families led to a decline in policyholder deaths, thus lowering costs for the insurance company.



courtney_bruh

  • Sr. Member
  • ****
  • Posts: 308
Answer to Question 1

ANS: D

Answer to Question 2

ANS: D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Signs and symptoms of a drug overdose include losing consciousness, fever or sweating, breathing problems, abnormal pulse, and changes in skin color.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library